In this study, 42 healthy male underwent a randomized, double blinded, parallel-group trial with either polyphenols or placebo during 31 days of high-carbohydrate and high-fat overfeeding. Changes in visceral, subcutaneous adipose tissue volumes and liver fat were measured using multi-gradient echo sequence. Visceral, subcutaneous adipose tissue volumes and liver fat increased significantly during overfeeding. The ratio VAT/SAT increased during overfeeding for the placebo group whereas this ratio slightly decreased for the polyphenol group.
Obesity is a complex multifactorial disease combining genetic factors still misunderstood as well as environmental factors mainly related to diet and physical inactivity. People with abdominal fat accumulation have commonly an altered metabolic profile. The increase of visceral adipose tissue1 (VAT) is associated with a higher risk to develop insulin resistance and type 2 diabetes unlike the expansion of subcutaneous adipose tissue (SAT). According to previous research2,3, adding polyphenols to the alimentation could protect the liver and muscle tissue from the accumulation of triglycerides by stimulating lipid oxidation and attenuates the effect of a high-fat diet.
The purpose of this work was to monitor morphological and content changes of abdominal adiposity and liver in particular before and after weight gain, using chemical-shift encoded MRI (CSE-MRI).
To be eligible, participants had to be a man aged between 18 and 55 years with a BMI between 23.0 kg/m2 and 27.0 kg/m2 and a low physical activity. Volunteers were excluded if they had family medical history of type 1 or 2 diabetes. Written informed consent was obtained from all the subjects. All volunteers underwent 31 days of high-carbohydrate and high-fat overfeeding by eating the equivalent of +50% of their daily energy requirements while maintaining their usual eating and sport activity habits. Subjects were divided randomly in two groups in a blinded way: one added to the overfeeding polyphenols capsules and the other placebos. This protocol was registered on the clinicaltrials.gov site (NCT02145780).
Subjects underwent two 3D spoiled-gradient multiple echo sequence (one before the overfeeding at D0 and the other at D31) on a 3T Ingenia Philips system. MRI acquisitions parameters were the following : 8 echoes (n x 1.15 ms TE with n=1, …,8), 10.3 ms TR, 384x420x320 mm3 FOV, 256x256x80 matrix size. This acquisition was made in 20.8 s apnea. The acquisition was performed on abdominal region, encompassing lumbar L1 to L5 and the liver. The segmentation of adipose tissue has been previously described4. The aim of this segmentation was to separate the subcutaneous adipose tissue (SAT) volume from the visceral adipose tissue (VAT) volume. The studied volume of adipose tissue was calculated between lumbar L2 to L4. PDFF parametric map5 was used to estimate the fat storage in liver.
The evolution of SAT, VAT, TAT (SAT+VAT) volumes, the ratio VAT/SAT and the PDFF in the liver were statistically studied. Effects of overfeeding and polyphenols were analyzed by a mixed model with two fixed effects (overfeeding and polyphenols) and one random effect (subjects). Then Tuckey post-hoc analyses were made. T-tests were applied to analyze the evolution of VAT/SAT between the two MRI and the difference of VAT/SAT ratio between polyphenols and placebo. P<0.05 was considered to be significant.
On a total of 42 subjects enrolled in the study, 2 did not complete the protocol and were excluded from the analyses (1 in each group).
The SAT volume significantly increased after overfeeding (overfeeding effect p<0.001) in both group (placebo group: +90 cm3, p=0.001; polyphenol group: +111 cm3 p<0.001) but there was no effect of polyphenol (polyphenol effect p=0.513) (figure 1). In the same way, the VAT volume also significantly increased after overfeeding (overfeeding effect p<0.001) in both group (placebo group: +129 cm3, p<0.001; polyphenol group: +88 cm3, p=0.028) nevertheless no polyphenol effect was found (polyphenol effect p=0.894). Then the evolution of the ratio VAT/SAT (considering as a metabolic marker) was studied between the two MRI in order to identify a potential effect of polyphenol (figure 2). The evolution of VAT/SAT ratio was significantly higher in placebo group than in polyphenol group (+0.07, p=0.051) meaning an effect of polyphenol supplementation on visceral/subcutaneous lipid deposition.
Two subjects (one in each group) presented an abnormal level of PDFF in the liver (PDFF>10%) at the beginning of the study, and were removed from the analysis. The PDFF in liver increased significantly in the two groups (overfeeding effect p<0.001) but there was no significant difference between placebo and polyphenol groups (polyphenol effect p=0.579).